Smilek D - Search Results

1

Competitive inhibition of antigen presentation in animal models of autoimmune disease.

Lock C, Smilek D, Gautam A, Vaysburd M, Dwivedy S, McDevitt H. Lock C, et al. Among authors: smilek d. Semin Immunol. 1991 Jul;3(4):247-55. Semin Immunol. 1991. PMID: 1718485 Review.

2

An immune response defect due to low levels of class II cell surface expression. Analysis of antigen presentation and positive selection.

Gilfillan S, Aiso S, Smilek D, Woodland DL, Palmer E, McDevitt HO. Gilfillan S, et al. Among authors: smilek d. J Immunol. 1991 Dec 15;147(12):4074-81. J Immunol. 1991. PMID: 1836476

3

EAE: a model for immune intervention with synthetic peptides.

Smilek DE, Gautam AM, Pearson C, Steinman L, McDevitt HO. Smilek DE, et al. Int Rev Immunol. 1992;9(3):223-30. doi: 10.3109/08830189209061792. Int Rev Immunol. 1992. PMID: 1285062 Review.

4

A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis.

Gautam AM, Pearson CI, Smilek DE, Steinman L, McDevitt HO. Gautam AM, et al. Among authors: smilek de. J Exp Med. 1992 Aug 1;176(2):605-9. doi: 10.1084/jem.176.2.605. J Exp Med. 1992. PMID: 1380066 Free PMC article.

5

Inhibition of experimental autoimmune encephalomyelitis by a nonimmunogenic non-self peptide that binds to I-Au.

Gautam AM, Pearson CI, Sinha AA, Smilek DE, Steinman L, McDevitt HO. Gautam AM, et al. Among authors: smilek de. J Immunol. 1992 May 15;148(10):3049-54. J Immunol. 1992. PMID: 1578131

6

Antigen recognition and peptide-mediated immunotherapy in autoimmune disease.

Smilek DE, Lock CB, McDevitt HO. Smilek DE, et al. Immunol Rev. 1990 Dec;118:37-71. doi: 10.1111/j.1600-065x.1990.tb00813.x. Immunol Rev. 1990. PMID: 1706681 Review. No abstract available.

7

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.

Smilek DE, Wraith DC, Hodgkinson S, Dwivedy S, Steinman L, McDevitt HO. Smilek DE, et al. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9633-7. doi: 10.1073/pnas.88.21.9633. Proc Natl Acad Sci U S A. 1991. PMID: 1719536 Free PMC article.

8

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

Wraith DC, Smilek DE, Mitchell DJ, Steinman L, McDevitt HO. Wraith DC, et al. Among authors: smilek de. Cell. 1989 Oct 20;59(2):247-55. doi: 10.1016/0092-8674(89)90287-0. Cell. 1989. PMID: 2478291

9

Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.

Gautam AM, Lock CB, Smilek DE, Pearson CI, Steinman L, McDevitt HO. Gautam AM, et al. Among authors: smilek de. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):767-71. doi: 10.1073/pnas.91.2.767. Proc Natl Acad Sci U S A. 1994. PMID: 7507253 Free PMC article.

10

Induction of a heterogeneous TCR repertoire in (PL/JXSJL/J)F1 mice by myelin basic protein peptide Ac1-11 and its analog Ac1-11[4A].

Pearson CI, Smilek DE, Danska JS, McDevitt HO. Pearson CI, et al. Among authors: smilek de. Mol Immunol. 1997 Aug;34(11):781-92. doi: 10.1016/s0161-5890(97)00058-8. Mol Immunol. 1997. PMID: 9444977 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters